Gandaglia Giorgio Ricercatore tempo determinato tipo aMedicineMed/24

Biography

Publications

Biography

Current position:

 

  • Research Fellow (Ricercatore a Tempo Determinato Tipo A, SSD MED/24), Vita-Salute San Raffaele University, Milan, Italy (since September 2020)
  • Full staff Urologist, Department of Urology, San Raffaele Hospital, Milan, Italy (since July 2017)

Education:

 

· Medical School completed with honours (July 2011), Vita-Salute San Raffaele University, Milan, Italy

· Residency in Urology completed with honours (July 2017), Vita-Salute San Raffaele University, Milan, Italy

· Fellow of the European Board of Urology (since July 2017)

· Research Fellow at the Cancer Prognostics and Health Outcomes Unit, Universitè de Montreal, Montreal, Canada from January 2013 to December 2013

· Clinical Fellow at the Department of Urology OLV Hospital, Aalst, Belgium, form April 2015 to April 2016

Position in scientific societies:

  • Member of the Scientific Committee of the Italian Society of Urology (SIU) since September 2017
  • Chairman of the Prostate Cancer Group, Young Academic Urologists Working Parties since November 2019
  • Associate member of the EAU Prostate Cancer Guidelines Panel since September 2019
  • Associate member of the EAU Robotic Urology Section (ERUS) since March 2020
  • Young Consulting Editor, European Urology Oncology since November 2017

Scientific activity:

  • Author or co-author of 309 peer-reviewed indexed publications according to PubMed
  • H-Index: 35 (according to Scopus)
  • Total citations: 5,090 (according to Scopus)
  • Author of 7 book chapters

Grants

  • Principal investigator, Ricerca Finalizzata, Giovani Ricercatori (GR-2018-12368369), Ministero della Salute: “The Role of Imaging Guided Surgery to Improve the Detection of Lymph Node metastases in Prostate Cancer Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection”
  • Principal investigator, Intuitive Surgical Clinical Research Grant: "Imaging Guided Lymph Node Dissection for Prostate Cancer Patients Undergoing Robot-Assisted Surgery”

Teaching:

  • Research Fellow (Ricercatore a Tempo Determinato Tipo A, SSD MED/24), Vita-Salute San Raffaele University, Milan, Italy (since September 2020)

Awards:

  • Reviewer of the Year 2015, European Urology
  • ESUI Vision Award 2019 for the best article on imaging published in the field of Urology
  • EAU Best Paper in Urological Literature Award 2019 for the best article on clinical research published in the year 201

 

Publications

LISTA DELLE PUBBLICAZIONI INDICIZZATE

  1. Gandaglia G, Ploussard G, Valerio M, Marra G, Moschini M, Martini A, Roumiguié M, Fossati N, Stabile A, Beauval JB, Malavaud B, Scuderi S, Barletta F, Afferi L, Rakauskas A, Gontero P, Mattei A, Montorsi F, Briganti A.  Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Eur Urol Oncol. 2020 Aug 23:S2588-9311(20)30123-1. doi:  10.1016/j.euo.2020.07.008. Epub ahead of print. PMID: 32847747.  
  2. Gandaglia G, Montorsi F, Briganti A. Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41. Eur Urol. 2020 Aug 13:S0302-2838(20)30619-9. doi:  10.1016/j.eururo.2020.07.039. Epub ahead of print. PMID: 32800726.
  3. Gandaglia G, Martini A, Ploussard G, Fossati N, Stabile A, De Visschere P, Borgmann H, Heidegger I, Steinkohl F, Kretschmer A, Marra G, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, Van den Bergh R, Ost P, Gontero P, Montorsi F,  Briganti A; EAU-YAU Prostate Cancer Working Group. External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who  Should Be Considered for an Extended Pelvic Lymph Node Dissection. Eur Urol.  2020 Aug;78(2):138-142. doi: 10.1016/j.eururo.2020.03.023. PMID: 32268944.
  4. Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Roumiguié M, Fossati N, Stabile A, Beauval JB, Malavaud B, Scuderi S, Barletta F, Moschini M, Zamboni S, Rakauskas A, Tian Z, Karakiewicz PI, De Cobelli F, Porpiglia F, Montorsi F, Briganti A. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic  Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer  Patients Undergoing Radical Prostatectomy. Eur Urol. 2020 Jun;77(6):733-741.  doi: 10.1016/j.eururo.2019.09.005. PMID: 31547938.
  5. Gandaglia G, Albers P, Abrahamsson PA, Briganti A, Catto JWF, Chapple CR, Montorsi F, Mottet N, Roobol MJ, Sønksen J, Wirth M, van Poppel H. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019. Eur Urol. 2019 Aug;76(2):142-150. doi: 10.1016/j.eururo.2019.04.033. PMID:  31092338.
  6. Gandaglia G, Soligo M, Battaglia A, Muilwijk T, Robesti D, Mazzone E, Barletta F, Fossati N, Moschini M, Bandini M, Joniau S, Karnes RJ, Montorsi F, Briganti A. Which Patients with Clinically Node-positive Prostate Cancer Should Be Considered for Radical Prostatectomy as Part of Multimodal Treatment? The Impact of Nodal Burden on Long-term Outcomes. Eur Urol. 2019 May;75(5):817-825.  doi: 10.1016/j.eururo.2018.10.042. PMID: 30409676.
  7. Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A. A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies. Eur Urol. 2019 Mar;75(3):506-514. doi:10.1016/j.eururo.2018.10.012. PMID:  30342844.
  8. Gandaglia G, van den Bergh RCN, Tilki D, Fossati N, Ost P, Surcel CI, Sooriakumaran P, Tsaur I, Valerio M, Kretschmer A, Zaffuto E, Salomon L, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Ploussard G;  European Association of Urology Young Academic Urologists Working Party on  Prostate Cancer (EAU-YAUWP). How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the  risk of misclassification? Development of a novel risk calculator. BJU Int. 2018  Nov;122(5):823-830. doi: 10.1111/bju.14391. PMID: 29772103.
  9. Gandaglia G, Bravi CA, Dell'Oglio P, Mazzone E, Fossati N, Scuderi S, Robesti D, Barletta F, Grillo L, Maclennan S, N'Dow J, Montorsi F, Briganti A.  The Impact of Implementation of the European Association of Urology Guidelines Panel Recommendations on Reporting and Grading Complications on Perioperative Outcomes after Robot-assisted Radical Prostatectomy. Eur Urol.2018 Jul;74(1):4-7. doi:10.1016/j.eururo.2018.02.025. PMID:  29544735.
  10. Gandaglia G, Fossati N, Karnes RJ, Boorjian SA, Colicchia M, Bossi A, Seisen T, Cozzarini C, Di Muzio N, Noris Chiorda B, Zaffuto E, Wiegel T, Shariat SF, Goldner G, Joniau S, Battaglia A, Haustermans K, De Meerleer G, Fonteyne V, Ost P, Van Poppel H, Montorsi F, Briganti A. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a  Large, Multi-institutional Series. Eur Urol. 2018 Apr;73(4):512-518. doi:  10.1016/j.eururo.2017.11.020. PMID: 29229176.
  11. Gandaglia G, Tilki D, Zaffuto E, Fossati N, Pompe RS, Dell'Oglio P, Graefen M, Montorsi F, Briganti A. Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions. Eur Urol Focus. 2019 Jul;5(4):545-549. doi: 10.1016/j.euf.2017.10.013. PMID: 29153885.
  12. Gandaglia G, Zaffuto E, Fossati N, Bandini M, Suardi N, Mazzone E, Dell'Oglio P, Stabile A, Freschi M, Montorsi F, Briganti A. Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer. BJU Int. 2018 Mar;121(3):421-427. doi:  10.1111/bju.14066. PMID: 29063734.
  13. Gandaglia G, Fossati N, Montorsi F, Briganti A. Reply to Alan Dal Pra, Stephane Supiot and Pirus Ghadjar's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative  Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After  Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7. Eur Urol. 2018 Feb;73(2):e36-e37. doi:  10.1016/j.eururo.2017.08.026. PMID: 28890246.
  14. Gandaglia G, Boorjian SA, Parker WP, Zaffuto E, Fossati N, Bandini M, Dell'Oglio P, Suardi N, Montorsi F, Karnes RJ, Briganti A. Impact of  Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific  Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival  Analysis. Eur Urol. 2017 Dec;72(6):910-917. doi: 10.1016/j.eururo.2017.06.001. PMID: 28622831

Il titolare del presente curriculum vitae, pubblicato online sul portale www.unisr.it, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.